Marianne Byrne
Datos Biográficos
| ID | 6094549 |
|---|---|
| NOMBRE | Marianne Byrne |
| NOMBRES | Marianne |
| APELLIDO | Byrne |
| FIRMA | BYRNE M |
| AFILIACIONES | UNSW Sydney |
| ORCID | 0000-0002-3489-2532 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 7 |
| TOTAL DE CITAS | 2 |
| TOTAL COMO AUTOR | 7 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2022 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 1 |
Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia
Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector
Significant gaps in HCV health literacy were perceived amongst the target audience groups. The comprehensive co-design and development processes utilised in HepPEd suggest the program will be well-placed to improve the HCV public health literacy of the prison sector and thereby enhance HCV testing and treatment rates amongst people in prison
Week Retention in Treatment With Extended-Release Subcutaneous Buprenorphine Depot Injections Among People With Opioid Dependence
Indivior
Tinkering with care
We examine how extended-release buprenorphine depot (BUP-XR) is put to use and made to work in implementation practices, attending to how care practices are challenged and adapted as a long-acting technology is introduced into service in opioid agonist treatment (OAT) in Australia. Our approach is informed by ideas in science and technology studies (STS) emphasising the irreducible entanglement of care practices and technology, and in particular …
The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence
Aims: This study examined the social, material and temporal effects of extended-release buprenorphine depot treatment (BUP-XR), among a group of participants commencing BUP-XR in Australia, and considered the situated potentials of these new opioid agonist treatment technologies. Methods: Using a longitudinal qualitative design, 36 participants (25 men, 11 women; mean age 44 years) were interviewed, with 32 followed-up, to generate accounts of BU…
You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting
Can a new formulation of opiate agonist treatment alter stigma
The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence
Aims: This study examined the social, material and temporal effects of extended-release buprenorphine depot treatment (BUP-XR), among a group of participants commencing BUP-XR in Australia, and considered the situated potentials of these new opioid agonist treatment technologies. Methods: Using a longitudinal qualitative design, 36 participants (25 men, 11 women; mean age 44 years) were interviewed, with 32 followed-up, to generate accounts of BU…
You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting
Can a new formulation of opiate agonist treatment alter stigma
The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence
Aims: This study examined the social, material and temporal effects of extended-release buprenorphine depot treatment (BUP-XR), among a group of participants commencing BUP-XR in Australia, and considered the situated potentials of these new opioid agonist treatment technologies. Methods: Using a longitudinal qualitative design, 36 participants (25 men, 11 women; mean age 44 years) were interviewed, with 32 followed-up, to generate accounts of BU…
Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector
Significant gaps in HCV health literacy were perceived amongst the target audience groups. The comprehensive co-design and development processes utilised in HepPEd suggest the program will be well-placed to improve the HCV public health literacy of the prison sector and thereby enhance HCV testing and treatment rates amongst people in prison
Week Retention in Treatment With Extended-Release Subcutaneous Buprenorphine Depot Injections Among People With Opioid Dependence
Indivior
Tinkering with care
We examine how extended-release buprenorphine depot (BUP-XR) is put to use and made to work in implementation practices, attending to how care practices are challenged and adapted as a long-acting technology is introduced into service in opioid agonist treatment (OAT) in Australia. Our approach is informed by ideas in science and technology studies (STS) emphasising the irreducible entanglement of care practices and technology, and in particular …
Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia
Medicine (6 obras) · HIV, Drug Use, Sexual Risk (5 obras) · Opioid Use Disorder Treatment (5 obras) · Psychology (5 obras) · Buprenorphine (4 obras) · Psychiatry (4 obras) · Opioid (3 obras) · Political science (3 obras) · Social Psychology (3 obras) · Sociology (3 obras)